Meet the Team
Scott Collins, PhD
Board of Directors President
I am passionate about eliminating the world’s problems through new and existing technologies alike. Most recently, I have applied this to human health. I can visualize the various pathways from technology creation to sustainable market, and guide companies more expeditiously towards success. I hate seeing companies flounder and technologies die on the vine. I like bringing clarity to ambiguity.
I am an experienced startup executive with cross-industry expertise spanning corporate formation through sale. I bring a multi-perspective approach to success, drawing from knowledge in entrepreneurship, biotechnology, tissue and organ engineering, biofabrication, communications, and software development. I am a creative out-of-the-box thinker who can combine existing technologies and novel innovations to sustainably solve problems and improve processes.
Timothy Sullivan
Board of Directors Member
A technology innovator and entrepreneur, I have created constructive disruptive technologies, products and services and grown more than a half dozen companies in several industry sectors over four decades. I have been granted 30+ US and international patents in the field of therapeutic drug and biologic delivery, my passion for over a decade has been the development and commercialization of advanced pharmaceutical drug/device combination products that protect the quality of human life.
Specialties: strategic foresight – see the big picture and higher order implications, innovate and commercialize breakthrough technologies, products and services that solve real-world problems, strategy development and execution, building and motivating high performance teams to make it happen.
Hilary Graham, PhD, MA
Board of Directors Member
I’m storyteller and commercial strategist with a growth mindset specializing in the molecular diagnostics and life sciences markets. People are my passion… both customer satisfaction and team development.
I lead Marketing for the Molecular Diagnostics Division of Bio-Techne, which includes the Asuragen, Exosome Diagnostics, Armored Molecular Controls and Companion Diagnostics franchises. I’m responsible for portfolio strategy, product management, and content marketing. Previously to Bio-Techne, I led marketing and application science for the xMAP multiplexing franchise at Luminex and was leading the launch of the INTELLIFLEX system when I departed. Before joining Luminex I worked in a variety of commercial and technical communications roles at Syneos Health and UT MD Anderson Cancer Center.